You just read:

Celsion Announces Presentation of Preclinical Data for GEN-1 IL-12 Immunotherapy in Combination with Avastin® and Doxil® at the AACR Annual Meeting 2016

News provided by

Celsion Corporation

Mar 16, 2016, 16:35 ET